Author:
Dangi Abha,Qureshi Tazeen,Chinnathambi Subashchandrabose,Kiran Marelli Udaya
Reference39 articles.
1. Protein misfolding, amyloid formation, and human disease: A summary of progress over the last decade;Chiti;Annu. Rev. Biochem.,2017
2. Alzheimer’s disease drug development pipeline: 2019, Alzheimer’s and Dementia;Cummings;Transl. Res. Clin. Interv.,2019
3. Cellular factors modulating the mechanism of tau protein aggregation;Fontaine;Cell. Mol. Life Sci.,2015
4. Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo Article Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo;Kaufman;Neuron.,2016
5. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer’s therapy;Soto;Nat. Med.,1998